Show your Support: EAACI, EFA and the European Parliament Interest Group on allergy and asthma launch a political call to action in Europe
On the 25th April 2017, Healthcare Professionals, patients and policymakers joined forces to call for action at national and European levels on allergy and asthma.
The political Call to Action in Europe ‘United action for allergy and asthma’ was launched as a multi-stakeholder partnership between the three co-initiators: the European Parliament Interest Group on Allergy and Asthma, the European Academy of Allergy and Clinical Immunology (EAACI), and the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA). The pan-European advocacy campaign aims to drive action on allergy and asthma – the most prevalent chronic diseases in Europe.
Allergy UK in an associated member of EEACI’s patient organisation committee and a member of EFA whereby the charity’s CEO, Carla Jones, is a member of the board.
Allergy UK represents the views and needs of the allergic community in the UK. We are asking for your support with this political ‘Call to Action’.
Targeted at EU and national policymakers, the Call to Action presents policy recommendations to EU Member States, the European Commission, the European Parliament and patients/civil society stakeholders, with the overarching objective to unite all strategic parties in Europe to help bring about effective policy responses to allergy and asthma through a collaborative and holistic approach, supporting patients’ rights.
In particular, it calls for:
- European strategies and programmes on allergy and asthma to be implemented in all Member States
- Greater funding for research to advance the understanding of allergy and asthma
- Better prevention and diagnosis to achieve early detection and allow timely and effective treatment
- Actions to address underlying triggers, such as air quality, food allergens and chemicals, and to improve the analysis of the root causes of allergic diseases
- Strengthened work to pioneer individualised treatment and progress personalised medicine.
The Call to Action is open until the end of September for endorsement by all interested parties wishing to join this move to support stronger and improved allergy and asthma policies.
You can pledge your support for the campaign via an online platform (www.callallergyasthma.eu). Allergy UK encourages you to take part in this initiative to be a part of this drive for political action.
Together, co-initiators and supporters stand united to create a healthier and happier future for the 220 million or more patients with allergy and asthma in Europe.